Press releases
New research from Genomics and Stanford Medicine indicates polygenic risk score screening could prevent almost a third of premature, preventable deaths
26 Nov 2024
Our research shows very high risk individuals reached the risk levels associated with usual starting screening ages 12.4 years earlier, on average. In other words, if a screening programme were devised on the basis of the average risk facing a 50-year-old, this high risk group would have the same predicted risk at the age of 37.6. Recommendations for earlier screening for genetically very high risk groups ranged from four years in advance for abdominal aortic aneurysm, to 22 years for hypertension.
ASHG 2024: New study from Genomics indicates individuals who have a genetic predisposition for high BMI may require tailored approaches to tackle obesity
12 Nov 2024
Our research shows that those at high genetic risk of obesity will need personalised support to help them stay at, or return to, a healthy weight.
Genomics releases new research showing significant link between genetic risk and obesity
16 Oct 2024
Genomics releases new research showing significant link between genetic risk and obesity
Genomics Announces David Thornton as President
30 Sep 2024
Genomics announces the appointment of David Thornton to the position of President, succeeding Professor Gil McVean, who will join the board as a non-executive Director.
Genomics plc identifies increased levels of undetected risk of heart disease in UK population
18 Sep 2024
Research by Genomics plc has identified that 8% of the adult population have the same risk of heart disease due to polygenic risk, as carriers of rare genetic mutations that cause familial hypercholesterolemia (FH).
Genomics Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex
17 Jul 2024
The three-year extension expands the range of therapeutic areas and genomic data insights and also explores the use of genomic risk to better define patient subgroups
Genomics and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial design
30 Apr 2024
The collaboration, across multiple therapeutic areas, will evaluate how polygenic risk scores could be used to improve clinical trial design and efficiency
Genomics and MassMutual's program enables understanding health risks through genetic testing
9 Apr 2024
The wellness offering utilizes advanced genetics to provide personalized risk information for common and preventable diseases, including heart disease, diabetes, breast and prostate cancer
Genomics plc selected as one of Bloomberg’s 25 UK Startups to Watch
24 Oct 2023
Genomics plc has been selected from among more than 1,500 applications to be included in Bloomberg’s inaugural 25 UK Startups to Watch list. Bloomberg canvassed the UK to find 25 startups that represent the diversity and innovation of the country's startup scene. The Editors wanted to hear about companies that are growing fast, working on something truly unique and come from a diverse group of founders from all over the UK. Genomics plc co-Founder, Professor Sir Peter Donnelly, was also one of three founders from companies in the list to be on stage at the Bloomberg Technology Summit to discuss the Genomics plc story and the wider life sciences/tech sector.
Genomics plc bolsters executive leadership team with two new hires
25 Nov 2022
Genomics plc has today announced that Mark Toms and Nick DeFilippo have joined its leadership team as Chief Medical Officer and Chief Commercial Officer, respectively. Both join the company’s executive leadership team.